Teva Pharmaceuticals (TEVA) Tanks On Q2 Financials

Adjust Comment Print

The company's previous year sales total was 5.04 Million. They are projecting Next Quarter growth of -3.8%. The Focused Wealth Management Inc holds 29,345 shares with $1.06M value, up from 17,900 last quarter. Teva Pharmaceutical Industries Limited makes up about 1.7% of Blue Granite Capital LLC's portfolio, making the stock its 28th largest position.

During last 5 trades the stock sticks nearly -5.42%. Bank Hapoalim BM boosted its stake in Teva Pharmaceutical Industries by 9.2% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,564,560 shares of the company's stock valued at $165,461,000 after buying an additional 801,106 shares during the last quarter. Finally, UBS Asset Management Americas Inc. increased its position in Teva Pharmaceutical Industries by 150.7% in the fourth quarter. Institutional investors and hedge funds own 56.20% of the company's stock.

Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) traded down 12.5933% during midday trading on Friday, hitting $20.7591. Earnings per share serves as an indicator of a company's profitability. The 7 months bearish chart indicates high risk for the $23.97 billion company. The stock has a market capitalization of $24.13 billion, a price-to-earnings ratio of 304.49 and a beta of 0.46.

Going out even further, the 200-Day Simple Moving Average is recorded -12.51% away from the current share price.

Teva also cut its 2017 sales guidance to $22.8 billion to $23.2 billion from its earlier view for $23.8 billion to $24.5 billion. Stock traders purchased 66,716 put options on the stock. This is an increase of approximately 864% compared to the typical daily volume of 6,922 put options. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since August 4, 2016 and is downtrending.

Two rebels, two Indian soldiers killed in Kashmir
Two Indian soldiers and two rebels were killed in separate armed clashes Thursday in the disputed Himalayan region of Kashmir. The fighting and India's counterinsurgency campaign since 1989 has left tens of thousands, mostly civilians, dead.


Teva Pharmaceutical Industries Limited (TEVA) surprised the stock market in its last reported earnings when it earned $1.06 a piece versus the consensus-estimated $1.03.

In case of Revenue Estimates, 18 analysts have provided their consensus Average Revenue Estimates for Teva Pharmaceutical Industries Limited as 5.73 Billion. These analysts have also projected a Low Estimate of $0.92/share and a High Estimate of $1.17/share. Sales, however, increased 13% year over year, mainly due to the inclusion of Actavis revenues. Currently Analysts have a mean recommendation of 2.50 on the shares.

WARNING: This story was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and worldwide copyright legislation. Teva Pharma had 77 analyst reports since July 21, 2015 according to SRatingsIntel.

Receive Teva Pharmaceutical Industries Limited News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries Limited with MarketBeat.com's FREE daily email newsletter. Long-term investors should review current trend forecasts and yearly or five-year trend graphs to understand whether the stock is bearish or bullish or to determine whether the company is performing well. Maxim Group maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Monday, February 13 with "Hold" rating. Maxim Group reissued an outperform rating and issued a $35.00 target price on shares of Teva Pharmaceutical Industries Limited in a research report on Wednesday, March 29th. Nineteen equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The stock of Cytec Industries Inc (NYSE:CYT) has "Hold" rating given on Wednesday, September 23 by Jefferies.

Teva Pharmaceutical Industries Limited is a pharmaceutical company.

Comments